Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies.
José María Sanchez-PinaMario Rodríguez RodriguezNerea Castro QuismondoRodrigo Gil MansoRafael ColmenaresDaniel Gil AlosMari Liz PacielloDenis ZafraCristina Garcia-SanchezCarolina VillegasClara CuellarGonzalo Carreño-TarragonaIrene ZamanilloMaría PozaRodrigo IñiguezXabier GutierrezRafael AlonsoAntonia RodríguezMaria Dolores FolgueiraRafael DelgadoJosé Miguel FerrariManuel LizasoainJosé María AguadoRosa AyalaJoaquín Martinez-LopezMaria CalbachoPublished in: European journal of haematology (2020)
Mortality of COVID-19 is significantly higher in patients with haematological malignancies compared to non-cancer patients. The impact of persistent viral shedding must be considered in order to re-start therapies and maintain infectious control measures.